Larry Todd Edwards, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 8,711 shares at $19.99 ($174K) on 2025-10-02, disclosed to the SEC on 2025-10-06.
Scheduled sale ($174k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.99 | 4,207 | $84K | 48.2% |
| 2 | $19.99 | 4,207 | $84K | 48.2% |
| 3 | $20.78 | 297 | $6K | 3.5% |
| Total | $20.02 avg | 8,711 | $174K | 100% |
| Filing → |
| ARQT | SELL | 2025-11-10 | $1.5M | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $28K | — | Filing → |